Merkel Cell Carcinoma

• EMA approval · 2026-03-24
  EMA Authorised: Zynyz (retifanlimab) — Incyte Biosciences Distribution B.V.

  The European Medicines Agency authorised Zynyz (retifanlimab) for Merkel cell carcinoma; it has orphan medicine designation and is marketed …

• FDA approval · 2020-06-30
  FDA Approved: BAVENCIO — Supplemental Application (EMD Serono, Inc.)

  FDA approved a supplemental application for BAVENCIO (avelumab) submitted by EMD Serono, Inc. This entry serves as the official notice of th…